Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
European Urology|May 10, 2002
Molecular aspects of bladder cancer III. Prognostic markers of bladder cancerI Kausch, A Böhle
Aktuelle Urologie|December 5, 2003
[Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology]I Kausch, A Böhle
European Urology|July 21, 2001
Bladder cancer. II. Molecular aspects and diagnosisI Kausch, A Böhle
Der Urologe. Ausg. A|August 5, 2003
[Non-invasive urinary diagnosis of bladder cancer. What do we know?]I Kausch, A Böhle
The Journal of Urology|June 7, 2002
Antisense oligonucleotide therapy in urologyI Kausch, A Böhle
The Journal of Urology|July 29, 1998
Treatment of recurrent penile condylomata acuminata with external application and intraurethral instillation of bacillus Calmette-GuerinA Böhle, C Doehn, I Kausch, et al.
Urology|February 20, 2004
Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculusA Meyer, I Kausch, S Krüger, et al.
European Urology|June 9, 2004
Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma modelI Kausch, H Jiang, C Brocks, et al.
Aktuelle Urologie|February 14, 2009
[BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study]D Jocham, J von Wietersheim, H Pflüger, et al.
Der Urologe. Ausg. A|November 1, 1994
[Superficial bladder cancer. Open questions]A Böhle
Pageof 10